FindTrial
Sign In

Dapagliflozin, SGLT2 inhibitor

2 trials

Sponsors

Hamano Takayuki

Conditions

Chronic kidney disease stage 3-4 and anemia of chronic kidney disease Dapagliflozin, diabetes mellitus, chronic kidney disease Anemia of chronic kidney disease, heart failure with reduced ejection fractionChronic kidney disease stage 3-4 with anemia of chronic kidney disease Dapagliflozin, diabetes mellitus, chronic kidney disease, anemia of chronic kidney disease, heart failure with reduced ejection fraction

Unknown Phase

The effects of dapagliflozin on anemia of chronic kidney disease (Study A)
RecruitingJPRN-jRCTs041200107
Hamano TakayukiChronic kidney disease stage 3-4 and anemia of chronic kidney disease Dapagliflozin, diabetes mellitus, chronic kidney disease Anemia of chronic kidney disease, heart failure with reduced ejection fraction
Start: 2021-04-05Target: 96Updated: 2026-06-29
The effects of dapagliflozin on anemia of chronic kidney disease (Study B)
RecruitingJPRN-jRCTs041200108
Hamano TakayukiChronic kidney disease stage 3-4 with anemia of chronic kidney disease Dapagliflozin, diabetes mellitus, chronic kidney disease, anemia of chronic kidney disease, heart failure with reduced ejection fraction
Start: 2021-05-31Target: 96Updated: 2026-06-29